MRSH Other Non-Current Liabilities decreased by 2.3% to $1.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $1.41B to $1.38B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -1.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.72B | $1.56B | $1.71B | $1.70B | $1.52B | $1.28B | $1.36B | $1.43B | $1.44B | $1.23B | $1.27B | $1.32B | $1.26B | $1.40B | $1.27B | $1.41B | $1.58B | $1.42B | $1.41B | $1.38B |
| QoQ Change | — | -9.1% | +9.5% | -1.0% | -10.3% | -15.8% | +6.4% | +5.1% | +0.3% | -14.7% | +3.3% | +4.1% | -4.4% | +10.7% | -9.4% | +11.1% | +12.2% | -10.0% | -0.5% | -2.3% |
| YoY Change | — | — | — | — | -11.6% | -18.1% | -20.4% | -15.5% | -5.5% | -4.3% | -7.0% | -8.0% | -12.3% | +13.9% | -0.2% | +6.6% | +25.1% | +1.6% | +11.6% | -1.8% |